SPHINX has been tested in vivo in the context of age-related macular degeneration (AMD), where it convincingly reduces choroidal neovascularization in rodents by promoting the expression of the anti-angiogenic VEGFA splice isoform (27). Here, VEGFA is linked to age-related macular degeneration.